Benign lipomatous neoplasm of other sites/unspecified

CD2_BENIGN_LIPO_NOS

lipoma: A benign, usually painless, well-circumscribed lipomatous tumor composed of adipose tissue.

Suggest a new description

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

473681

1. Apply sex-specific rule

None

473681

2. Check conditions

None

473681

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 D17.7&, D17.9&
  • Hospital discharge: ICD-9 214
  • Hospital discharge: ICD-8 214
  • Cause of death: ICD-10 D17.7&, D17.9&
  • Cause of death: ICD-9 214
  • Cause of death: ICD-8 214

2 out of 7 registries used, show all original rules.

3167

4. Check minimum number of events

None

3167

5. Include endpoints

None

3167

6. Filter based on genotype QC (FinnGen only)

3043

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF2

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 30785 17363 13117
Only index persons 24876 14525 10351
Unadjusted period prevalence (%)
Whole population 0.44 0.50 0.37
Only index persons 0.48 0.53 0.40
Median age at first event (years)
Whole population 50.85 51.23 50.21
Only index persons 48.60 49.32 47.59

-FinnGen-

Key figures

All Female Male
Number of individuals 3043 1690 1353
Unadjusted period prevalence (%) 0.67 0.66 0.68
Median age at first event (years) 48.56 47.45 49.95

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

Mortality – FinRegistry

Association

Association between endpoint CD2_BENIGN_LIPO_NOS and mortality.

Females

Parameter HR [95% CI] p-value
CD2_BENIGN_LIPO_NOS 0.969 [0.87, 1.08] 0.568
Birth year 0.99 [0.98, 1.0] 0.019

During the follow-up period (1.1.1998 — 31.12.2019), 696 out of 6136 females with CD2_BENIGN_LIPO_NOS died.

Males

Parameter HR [95% CI] p-value
CD2_BENIGN_LIPO_NOS 0.905 [0.81, 1.01] 0.064
Birth year 0.986 [0.98, 1.0] 0.003

During the follow-up period (1.1.1998 — 31.12.2019), 748 out of 5331 males with CD2_BENIGN_LIPO_NOS died.

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_LIPO_NOS.

N-year risk Females Males
1 0.095% 0.161%
5 0.486% 0.9%
10 1.278% 2.481%
15 2.285% 4.738%
20 4.05% 8.049%

Relationships between endpoints

Index endpoint: CD2_BENIGN_LIPO_NOS – Benign lipomatous neoplasm of other sites/unspecified

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data